Tien-Li Lee
Gründer bei Aardvark Therapeutics, Inc.
Aktive Positionen von Tien-Li Lee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 01.03.2017 | - |
| Vorstandsvorsitzender | 01.03.2017 | - | |
| Gründer | 01.01.2017 | - |
Karriereverlauf von Tien-Li Lee
Ehemalige bekannte Positionen von Tien-Li Lee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Direktor/Vorstandsmitglied | 01.11.2018 | 27.08.2023 |
| SCILEX HOLDING COMPANY | Direktor/Vorstandsmitglied | 09.11.2022 | 27.08.2023 |
| Independent Dir/Board Member | 09.11.2022 | 27.08.2023 | |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Direktor/Vorstandsmitglied | 01.03.2019 | 01.11.2022 |
| Independent Dir/Board Member | 01.03.2019 | 01.11.2022 | |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01.03.2014 | 01.03.2017 |
Ausbildung von Tien-Li Lee
| University of California San Diego | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCILEX HOLDING COMPANY | Health Technology |
| Private Unternehmen | 4 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA. | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
- Börse
- Insiders
- Tien-Li Lee
- Erfahrung
